title: Is serum Interleukin-17 associated with early atherosclerosis in obese patients?
abstract: Atherosclerosis is a chronic inflammatory process of the vessel walls, and CD4+ T-cells are peculiar to both human and murine atherosclerotic lesions. There is a recent line of research favoring hypothetic allergic mechanisms in the genesis of atherosclerosis and, consequently, coronary artery disease (CAD), among which Interleukin (IL)-17 appears to be a key cytokine regulating local tissue inflammation. The objective was to add a piece of information on the role of IL-17 in the genesis of atherosclerosis. Eighty obese patients with normal liver enzyme levels but presenting with ultrasonographic evidence of NAFLD formed the population of this cross-sectional study. Anthropometric measures, data on excess adiposity, metabolic profile, serum concentrations of IL-17, eotaxin-3, IL-8, and CCL4/MIP1β, C-reactive protein, fibrinogen, ferritin, TNF-α, as well carotid intima-media thickness (IMT), a marker of atherosclerosis, and the main risk factors for CAD, such as blood pressure and smoking status, but also less determinant ones such as degree of NAFLD severity, Intramuscular Triglyceride storage and Resting Metabolic Rate were evaluated. Serum concentrations of Il-17 were detected as related to those of inflammatory cytokines, IL-6, IFN-γ and TNF-α. Furthermore, circulating levels of IL-17 were linked to those mirroring allergic process, IL-8, CCL4/MIP1β and eotaxin. Early atherosclerosis, evidenced as increased IMT, was not associated with circulating IL-17 levels. At multiple regression,IMT was predicted, other than by age, by the amount of the visceral adiposity, expressed as visceral adipose tissue at ultrasonography, and by serum eotaxin. In conclusion, a strong relationship was found between the IL-17-related chemokine eotaxin and IMT. The association found between the amount of visceral fat and circulating levels of eotaxin on the one hand, and IMT on the other, could reinforce the hypothesis that IL-17, released by the visceral adipose tissue, induces eotaxin secretion via the smooth muscle cells present in the atheromatosus vessels.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Tarantino
authors.forename: Susan
authors.initials: S
authors.lastname: Costantini
authors.forename: Carmine
authors.initials: C
authors.lastname: Finelli
authors.forename: Francesca
authors.initials: F
authors.lastname: Capone
authors.forename: Eliana
authors.initials: E
authors.lastname: Guerriero
authors.forename: Nicolina
authors.initials: N
authors.lastname: La Sala
authors.forename: Saverio
authors.initials: S
authors.lastname: Gioia
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Castello
mesh_terms: D000328:Adult; D050197:Atherosclerosis / Q000097:blood* / Q000150:complications*; D059168:Carotid Intima-Media Thickness; D005260:Female; D006801:Humans; D020381:Interleukin-17 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D065626:Non-alcoholic Fatty Liver Disease / Q000097:blood / Q000150:complications; D009765:Obesity / Q000097:blood* / Q000150:complications*
chemical_list: D020381:Interleukin-17
references.citation: J Immunol. 2010 Dec 1;185(11):6947-59
references.pmid: 21037091
references.citation: Inflamm Allergy Drug Targets. 2009 Dec;8(5):383-9
references.pmid: 20025586
references.citation: Endocrine. 2013 Oct;44(2):380-5
references.pmid: 23188694
references.citation: Atherosclerosis. 2009 Aug;205(2):477-80
references.pmid: 19200543
references.citation: Circulation. 2010 Apr 20;121(15):1746-55
references.pmid: 20368519
references.citation: World J Gastroenterol. 2011 Sep 7;17(33):3785-94
references.pmid: 21987620
references.citation: J Gastroenterol Hepatol. 2007 Mar;22(3):293-303
references.pmid: 17295757
references.citation: Immunity. 2011 Feb 25;34(2):149-62
references.pmid: 21349428
references.citation: Eur J Clin Invest. 1997 May;27(5):398-404
references.pmid: 9179547
references.citation: Int J Obes Relat Metab Disord. 2002 Jul;26(7):953-60
references.pmid: 12080449
references.citation: J Reprod Immunol. 2010 Nov;86(2):126-32
references.pmid: 20594599
references.citation: Atherosclerosis. 1999 Jul;145(1):33-43
references.pmid: 10428293
references.citation: Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):194-9
references.pmid: 16239601
references.citation: AJR Am J Roentgenol. 2009 Apr;192(4):909-14
references.pmid: 19304694
references.citation: Diabetes Metab Syndr Obes. 2013 Oct 24;6:403-19
references.pmid: 24179379
references.citation: Oral Dis. 2008 Nov;14(8):705-12
references.pmid: 19193200
references.citation: J Pediatr. 1982 Nov;101(5):656-60
references.pmid: 7131136
references.citation: Endocr Rev. 2012 Feb;33(1):71-108
references.pmid: 22240242
references.citation: Atherosclerosis. 2014 Apr;233(2):636-640
references.pmid: 24553454
references.citation: Atherosclerosis. 2013 Oct;230(2):258-67
references.pmid: 24075754
references.citation: Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):1013-8
references.pmid: 8696940
references.citation: Clin Chim Acta. 2014 Apr 20;431:33-9
references.pmid: 24508995
references.citation: Br J Pharmacol. 1991 May;103(1):1153-9
references.pmid: 1652342
references.citation: Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1503-8
references.pmid: 15178568
references.citation: Am J Respir Crit Care Med. 1999 Jun;159(6):1933-42
references.pmid: 10351942
references.citation: J Atheroscler Thromb. 2001;8(1):30-2
references.pmid: 11686313
references.citation: Neurol Res. 2011 Dec;33(10):1016-24
references.pmid: 22196753
references.citation: Obesity (Silver Spring). 2010 Sep;18(9):1754-61
references.pmid: 20035275
references.citation: Am Heart J. 2001 May;141(5):694-703
references.pmid: 11320355
references.citation: Clin Invest Med. 2008;31(1):E24-9
references.pmid: 18312746
references.citation: Clin Immunol. 2011 Nov;141(2):152-60
references.pmid: 21872532
references.citation: Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):863-70
references.pmid: 23349188
references.citation: Eur Heart J. 1994 Aug;15(8):1020-7
references.pmid: 7988592
references.citation: J Exp Med. 2010 Oct 25;207(11):2479-91
references.pmid: 20921287
references.citation: Eur Heart J. 2013 Feb;34(8):570-7
references.pmid: 22956509
references.citation: J Transl Med. 2012 Mar 16;10:50
references.pmid: 22424154
references.citation: J Immunol. 2010 Nov 15;185(10):5820-7
references.pmid: 20952673
references.citation: Cytokine Growth Factor Rev. 2010 Dec;21(6):449-53
references.pmid: 21084215
references.citation: ISRN Inflamm. 2013 Dec 22;2013:139239
references.pmid: 24455420
references.citation: Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):273-80
references.pmid: 22116098
references.citation: Int J Obes (Lond). 2009 Jan;33(1):151-6
references.pmid: 18982006
references.citation: Muscle Nerve. 2008 Jun;37(6):679-93
references.pmid: 18506712
references.citation: PLoS One. 2014 Sep 30;9(9):e105610
references.pmid: 25268946
references.citation: Mayo Clin Proc. 2013 Nov;88(11):1259-65
references.pmid: 24138963